Gerard Guillet

Poitiers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study.

Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study.

Journal: European journal of dermatology : EJD

Published: May 18, 2021

Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.

Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: January 09, 2020

The burden of chronic urticaria: French baseline data from the international real-life AWARE study.

The burden of chronic urticaria: French baseline data from the international real-life AWARE study.

Journal: European journal of dermatology : EJD

Published: March 05, 2019

Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study.

Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study.

Journal: The World Allergy Organization journal

Published: June 14, 2018

Characterization of skin Th17 transcriptional profiles in psoriatic patients under adalimumab biotherapy.

Characterization of skin Th17 transcriptional profiles in psoriatic patients under adalimumab biotherapy.

Journal: European journal of dermatology : EJD

Published: November 25, 2017

Chronic Pain in Patients with Skin Disorders.

Chronic Pain in Patients with Skin Disorders.

Journal: Acta dermato-venereologica

Published: May 13, 2017

Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.

Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.

Journal: PloS one

Published: April 25, 2017

Paraneoplastic pemphigus: Retrospective study of a case series

Paraneoplastic pemphigus: Retrospective study of a case series

Journal: Annales de dermatologie et de venereologie

Published: April 04, 2017

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.

Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial.

Journal: Journal of the American Academy of Dermatology

Published: March 09, 2017

Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.

Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 02, 2016

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Journal: Lancet (London, England)

Published: March 14, 2016

Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study.

Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study.

Journal: PloS one

Published: February 24, 2016

Showing 1-12 of 35

Last Updated: 09/26/2026